| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |